Compare WOLF & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WOLF | IRMD |
|---|---|---|
| Founded | 1987 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2025 | 2014 |
| Metric | WOLF | IRMD |
|---|---|---|
| Price | $24.10 | $82.55 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $14.33 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 3.0M | 81.5K |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 0.86 |
| Revenue | ★ $1,385,982,000.00 | $83,814,000.00 |
| Revenue This Year | N/A | $12.38 |
| Revenue Next Year | $7.43 | $11.31 |
| P/E Ratio | ★ N/A | $95.60 |
| Revenue Growth | ★ 19.00 | 14.43 |
| 52 Week Low | $1.20 | $67.84 |
| 52 Week High | $80.82 | $107.90 |
| Indicator | WOLF | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 39.94 | 31.72 |
| Support Level | $23.37 | $76.95 |
| Resistance Level | $35.18 | $88.93 |
| Average True Range (ATR) | 1.75 | 2.20 |
| MACD | -0.03 | -0.23 |
| Stochastic Oscillator | 5.44 | 14.56 |
Wolfspeed Inc is an innovator of wide bandgap semiconductors, focused on silicon carbide materials and devices for power applications. Its product families include silicon carbide materials and power devices. Its products are targeted for various applications in the Automotive domain, including electric vehicles and fast charging, as well as existing and emerging applications in the Industrial & Energy domain such as AI data centers, grid modernization and renewable energy and storage as well as aerospace and defense. The company also use contract manufacturers, some of which include captive lines, for certain products and aspects of product fabrication, assembly and packaging. The company has one reportable segment. Majority of revenue comes from United States followed by Hong Kong.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.